ScreenerHero

PTPI Petros Pharmaceuticals, Inc.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · petrospharma.com
0.0040USD-27.27%Mkt Cap: 169489 $P/E: 0.00

Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary software as a service (SaaS) platform and Software as a medical device web application designed to assist pha…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap169.49K USD
Enterprise Value-3.34M USD
Revenue (TTM)—
Gross Profit0 USD
Net Income (TTM)1.91M USD
Revenue/Share—
Last Price0.0040 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)0.00
P/E (Forward)-0.00
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.24
EPS (TTM)0.08
EPS (Forward)-1.09
52W Range
0.00207% of range0.0320
52W High0.0320 USD
52W Low0.0020 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE66.66%
ROA37.06%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.73M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-1075.06%
Net Debt-3.49M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio1.25
Quick Ratio1.23
Book Value/Sh0.02 USD
Cash/Share0.08 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateMay 1, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.42.37M
Float28.94M
Insiders25.59%
Institutions10.24%
Short Interest
Short Ratio0.0d
Short % Float0.77%
Short % Out.0.76%
Shares Short238.06K
Short (prev mo.)493.83K
Technical
SMA 500.0043 (-7.0%)
SMA 2000.0062 (-35.9%)
Beta1.88
S&P 52W Chg16.45%
Avg Vol (30d)80.02K
Avg Vol (10d)161.53K
Technical Indicators
RSI (14)46.2
MACD0.0004
MACD Signal0.0004
MACD Hist.-0.0000
BB Upper0.0072 USD
BB Middle0.0046 USD
BB Lower0.0019 USD
BB Width115.04%
ATR (14)0.0012 USD
Vol Ratio (20d)0.02x